OTCBB:PMCB

Pharmacyt Biotch Stock Forecast

etoro logo Buy PMCB
*Your capital is at risk
$0.600
-0.0047 (-0.777%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of PMCB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PMCB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Pharmacyt Biotch
(Updated on Jul 24, 2026)

Sell candidate since Jul 16, 2026 Loss -9.05%

The Pharmacyt Biotch stock price fell by -0.777% on the last day (Friday, 24th Jul 2026) from $0.605 to $0.600. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 8.09% from a day low at $0.581 to a day high of $0.628. The price has fallen in 8 of the last 10 days and is down by -13.84% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -32 thousand shares and in total, 82 thousand shares were bought and sold for approximately $49.29 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.629) are considered to be a "second chance" to get out. According to the fan-theory $0.411 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

PMCB Signals & Forecast

There are few to no technical positive signals at the moment. The Pharmacyt Biotch stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.620 and $0.712. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 16, 2026, and so far it has fallen -27.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pharmacyt Biotch stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0470 between high and low, or 8.09%. For the last week the stock has had daily average volatility of 6.66%.

Pharmacyt Biotch is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PMCB) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Pharmacyt Biotch to open at $0.603, and during the day (based on 14 day Average True Range), to move between $0.577 and $0.623, which gives a possible trading interval of +/-$0.0466 (+/-8.09%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 8.09% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.700, some $0.0999 (16.65%) from the current price of $0.600, our system finds the risk reward not very attractive.

Is Pharmacyt Biotch stock A Buy?

Pharmacyt Biotch holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.667 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $0.603 ( 0.500%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PMCB Performance

Trading levels for PMCB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.650 8.33%
R2 0.632 5.34%
R1 0.621 3.49%
Price 0.600
S1 0.585 -2.49%
S2 0.574 -4.34%
S3 0.556 -7.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.732 21.98%
R2 0.718 19.61%
R1 0.700 16.65%
Price 0.600
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Pharmacyt Biotch Stock and on which exchange is it traded?
The symbol for Pharmacyt Biotch is PMCB and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Pharmacyt Biotch Stock?
Pharmacyt Biotch holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Pharmacyt Biotch Stock?
Pharmacyt Biotch Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharmacyt Biotch Stock.

What's the current price of Pharmacyt Biotch Stock?
As of the end of day on the Jul 24, 2026, the price of an Pharmacyt Biotch (PMCB) share was $0.600.

What is the 52-week high and low for Pharmacyt Biotch Stock?
The 52-week high for Pharmacyt Biotch Stock is $1.51 and the 52-week low is $0.580.

What is the market capitalization of Pharmacyt Biotch Stock?
As of the Jul 24, 2026, the market capitalization of Pharmacyt Biotch is 4.078M.
Click to get the best stock tips daily for free!
ABOUT PHARMACYT BIOTCH
Pharmacyt Biotch
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
ROP
$331.60
10.78% Jun 24
JLL
$299.78
8.56% Jun 24
NMRK
$15.02
2.46% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE